Vaseem Mahboob - 27 Oct 2026 Form 4 Insider Report for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
29 Oct 2026, 18:46:31 UTC
Prior SEC filing
11 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Traci S. Umberger as attorney-in-fact for Vaseem Mahboob
Filing notes and source

Key filing fact

Vaseem Mahboob filed Form 4 for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) on 29 Oct 2026.

Key facts

  • This page summarizes Vaseem Mahboob's Form 4 filing for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS).
  • 9 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 29 Oct 2026, 18:46.

Change

  • Previous filing in this sequence was filed on 11 Aug 2026.
  • Current net transaction value: -$2,408,590.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001655157 Primary reporting owner

Mahboob Vaseem

Relationship
Chief Financial Officer
Address
3933 LAKE WASHINGTON BLVD NE, SUITE 200, KIRKLAND
Signature
/s/ Traci S. Umberger as attorney-in-fact for Vaseem Mahboob
Signature date
29 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KMTS transaction

Common Shares

Options Exercise

Transaction value
Shares
+34,809
Change %
+57%
Price
$17.00*
Shares after
95,418
Date
27 Oct 2026
Ownership
Direct
Footnotes
F1
KMTS transaction

Common Shares

Sale

Transaction value
-$1,045,784
Shares
-34,809
Change %
-36%
Price
$30.04
Shares after
60,609
Date
27 Oct 2026
Ownership
Direct
Footnotes
F1, F2
KMTS transaction

Common Shares

Options Exercise

Transaction value
Shares
+39,903
Change %
+66%
Price
$17.00*
Shares after
100,512
Date
28 Oct 2026
Ownership
Direct
Footnotes
F1, F2
KMTS transaction

Common Shares

Sale

Transaction value
-$1,216,303
Shares
-39,903
Change %
-40%
Price
$30.48
Shares after
60,609
Date
28 Oct 2026
Ownership
Direct
Footnotes
F1, F3
KMTS transaction

Common Shares

Options Exercise

Transaction value
Shares
+4,788
Change %
+7.9%
Price
$17.00*
Shares after
65,397
Date
29 Oct 2026
Ownership
Direct
Footnotes
F1, F2
KMTS transaction

Common Shares

Sale

Transaction value
-$146,503
Shares
-4,788
Change %
-7.3%
Price
$30.60
Shares after
60,609
Date
29 Oct 2026
Ownership
Direct
Footnotes
F1, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KMTS transaction Derivative

Options

Options Exercise

Transaction value
Shares
-34,809
Change %
-22%
Price
$0.000000*
Shares after
124,191
Date
27 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
34,809
Exercise price
$17.00
Footnotes
F5
KMTS transaction Derivative

Options

Options Exercise

Transaction value
Shares
-39,903
Change %
-32%
Price
$0.000000*
Shares after
84,288
Date
28 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
39,903
Exercise price
$17.00
Footnotes
F6
KMTS transaction Derivative

Options

Options Exercise

Transaction value
Shares
-4,788
Change %
-5.7%
Price
$0.000000*
Shares after
79,500
Date
29 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,788
Exercise price
$17.00
Footnotes
F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 7 footnotes

Footnote F1

This reported transaction is a scheduled exercise and sale pursuant to a Rule 10b5-1 trading plan adopted on November 5, 2025.

Footnote F2

The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $30.0000 to $30.4300. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

Footnote F3

The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $30.0100 to $30.9800. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

Footnote F4

The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $30.3500 to $31.0400. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

Footnote F5

Includes 91,066 fully vested options as of the transaction date, with the remaining 33,125 options vesting in equal monthly installments through March 6, 2027.

Footnote F6

Includes 51,163 fully vested options as of the transaction date, with the remaining 33,125 options vesting in equal monthly installments through March 6, 2027.

Footnote F7

Includes 46,375 fully vested options as of the filing date, with the remaining 33,125 options vesting in equal monthly installments through March 6, 2027.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .